The business case for quality improvement oral anticoagulation for atrial fibrillation

Adam J. Rose*, Dan R. Berlowitz, Arlene S. Ash, Al Ozonoff, Elaine M. Hylek, Jeremy D. Goldhaber-Fiebert

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

39 Scopus citations

Fingerprint

Dive into the research topics of 'The business case for quality improvement oral anticoagulation for atrial fibrillation'. Together they form a unique fingerprint.

Keyphrases

Nursing and Health Professions

Pharmacology, Toxicology and Pharmaceutical Science

Agricultural and Biological Sciences